Systematisches Handeln – Notfälle der medikamentösen Tumortherapie!

por Bögemann, Martin
Publicado 2022

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors

por Saad, Fred, Bögemann, Martin, Suzuki, Kazuhiro, Shore, Neal
Publicado 2021

Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management

por Kessel, Katharina, Bernemann, Christof, Bögemann, Martin, Rahbar, Kambiz
Publicado 2021

Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practice

por Bögemann, Martin, Facchini, Gaetano, Bauernhofer, Thomas, Cathomas, Richard, Xylinas, Evanguelos, Tombal, Bertrand
Publicado 2023

Radioligand therapy using [(177)Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis

por Seifert, Robert, Kessel, Katharina, Schlack, Katrin, Weckesser, Matthias, Bögemann, Martin, Rahbar, Kambiz
Publicado 2020

Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [(18)F]F-PSMA 1007 PET

por Relt, Elisabeth, Roll, Wolfgang, Claesener, Michael, Bögemann, Martin, Weckesser, Matthias, Rahbar, Kambiz
Publicado 2022

Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer

por Rahbar, Kambiz, Afshar-Oromieh, Ali, Seifert, Robert, Wagner, Stefan, Schäfers, Michael, Bögemann, Martin, Weckesser, Matthias
Publicado 2018

Do fasting or high caloric drinks affect the physiological uptake of fluorine-18 prostate-specific membrane antigen-1007 in liver and bowel?

por Rahbar, Kambiz, Afshar-Oromieh, Ali, Seifert, Robert, Wagner, Stefan, Schäfers, Michael, Bögemann, Martin, Weckesser, Matthias
Publicado 2019

Comparison of isolation platforms for detection of circulating renal cell carcinoma cells

por Maertens, Yvonne, Humberg, Verena, Erlmeier, Franziska, Steffens, Sandra, Steinestel, Julie, Bögemann, Martin, Schrader, Andres Jan, Bernemann, Christof
Publicado 2017

Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving (177)Lu-PSMA-617 Radioligand Therapy

por Kessel, Katharina, Seifert, Robert, Weckesser, Matthias, Roll, Wolfgang, Humberg, Verena, Schlack, Katrin, Bögemann, Martin, Bernemann, Christof, Rahbar, Kambiz
Publicado 2020

Evaluation of (68)Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving (177)Lu-PSMA-617 Therapy: A Radiomics Analysis

por Roll, Wolfgang, Schindler, Philipp, Masthoff, Max, Seifert, Robert, Schlack, Katrin, Bögemann, Martin, Stegger, Lars, Weckesser, Matthias, Rahbar, Kambiz
Publicado 2021

Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapy

por Seifert, Robert, Kessel, Katharina, Schlack, Katrin, Weckesser, Matthias, Kersting, David, Seitzer, Konstantin E., Weber, Manuel, Bögemann, Martin, Rahbar, Kambiz
Publicado 2021

Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study

por Ahmadzadehfar, Hojjat, Rahbar, Kambiz, Kürpig, Stefan, Bögemann, Martin, Claesener, Michael, Eppard, Elisabeth, Gärtner, Florian, Rogenhofer, Sebastian, Schäfers, Michael, Essler, Markus
Publicado 2015

Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST

por Heitkötter, Birthe, Trautmann, Marcel, Grünewald, Inga, Bögemann, Martin, Rahbar, Kambiz, Gevensleben, Heidrun, Wardelmann, Eva, Hartmann, Wolfgang, Steinestel, Konrad, Huss, Sebastian
Publicado 2016

Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid

por Heitkötter, Birthe, Steinestel, Konrad, Trautmann, Marcel, Grünewald, Inga, Barth, Peter, Gevensleben, Heidrun, Bögemann, Martin, Wardelmann, Eva, Hartmann, Wolfgang, Rahbar, Kambiz, Huss, Sebastian
Publicado 2018

The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion Status

por van Strijp, Dianne, de Witz, Christiane, Heitkötter, Birthe, Huss, Sebastian, Bögemann, Martin, Baillie, George S., Houslay, Miles D., Bangma, Chris, Semjonow, Axel, Hoffmann, Ralf
Publicado 2019

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape

por Doehn, Christian, Bögemann, Martin, Grünwald, Viktor, Welslau, Manfred, Bedke, Jens, Schostak, Martin, Wolf, Thomas, Ehneß, Rainer, Degenkolbe, Elisa, Witecy, Stefanie, Goebell, Peter J.
Publicado 2022

Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients

por Schlack, Katrin, Seitzer, Konstantin, Wüstmann, Neele, Humberg, Verena, Grundmann, Norbert, Steinestel, Julie, Tiedje, Dorothee, Rahbar, Kambiz, Krabbe, Laura-Maria, Bögemann, Martin, Schrader, Andres J., Bernemann, Christof
Publicado 2022

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer

por Wüstmann, Neele, Seitzer, Konstantin, Humberg, Verena, Vieler, Julia, Grundmann, Norbert, Steinestel, Julie, Tiedje, Dorothee, Duensing, Stefan, Krabbe, Laura-Maria, Bögemann, Martin, Schrader, Andres Jan, Bernemann, Christof, Schlack, Katrin
Publicado 2023

(177)Lu-Prostate-Specific Membrane Antigen Ligand After (223)Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience

por Sartor, Oliver, la Fougère, Christian, Essler, Markus, Ezziddin, Samer, Kramer, Gero, Ellinger, Jörg, Nordquist, Luke, Sylvester, John, Paganelli, Giovanni, Peer, Avivit, Bögemann, Martin, Meltzer, Jeffrey, Sandström, Per, Verholen, Frank, Song, Daniel Y.
Publicado 2022